These results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assistance the idea of targeting ACKR3 as a unique way to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Problems.A brand new analyze reveals the compound conolidine